United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72789-325_40bb3383-082a-7a68-e063-6394a90a8da3
- Product NDC
- 72789-325
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20031211
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (72789-325-30) · 72789-325-30
- 150 TABLET in 1 BOTTLE, PLASTIC (72789-325-77) · 72789-325-77
- 90 TABLET in 1 BOTTLE, PLASTIC (72789-325-90) · 72789-325-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →